« previous next »
Pages: [1]

Author Topic: (Abst.) Impact of the 2017 McDonald criteria on accuracy of MS diagnoses  (Read 123 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9670
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Impact of the 2017 McDonald criteria on accuracy of MS diagnoses
« on: November 02, 2018, 07:30:04 am »
I was diagnosed with MS 38 years ago and have been watching developments in the MS field during that time. It seems that decades have gone by, and they still know very little about this disease.


From PubMed (November 2, 2018), an abstract of an article called "Misdiagnosis of MS: Impact of the 2017 McDonald criteria on clinical practice," which appeared in Neurology:



https://www.ncbi.nlm.nih.gov/pubmed/30381369
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
103 Views 		Last post March 11, 2017, 07:08:23 am
by agate
0 Replies
82 Views 		Last post May 27, 2017, 04:21:39 pm
by agate
2 Replies
186 Views 		Last post January 24, 2018, 06:24:45 pm
by agate
0 Replies
25 Views 		Last post April 29, 2021, 08:03:54 pm
by agate
0 Replies
22 Views 		Last post November 06, 2021, 09:09:17 pm
by agate